Adnan Hussain

Government Departments aim to secure value for money in meeting their facilities management requirements. The evaluation of either an in-house, outsourced, or a delivery model which is a combination of insourced and outsourced components will be evaluated on price and quality including the social value impacts such as tackling regional inequality with new skills and jobs, or ensuring those in disadvantaged groups have equal chance to become part of a diverse, resilient workforce. A minimum overall weight of 10% in the overall score is ascribed to Social Value.

The National Institute for Health and Care Excellence (NICE) considered the impact of its severity modifier as part of its appraisal of Enhertu for HER2-low metastatic breast cancer. However, even with the severity weighting applied, NICE concluded that the treatment was not cost-effective at the price offered by the company and therefore could not recommend it for routine National Health Service use.

The Department recognises the disappointment this decision caused for patients and the breast cancer community, particularly as Enhertu is the only breast cancer treatment that NICE has been unable to recommend for NHS use in the last eight years. In light of NICE’s updated cost-effectiveness threshold, NICE, NHS England, and the manufacturers have resumed discussions to explore whether a commercial agreement can be reached that would make Enhertu available to NHS patients.

Through the introduction of England's first ever targeted prostate cancer screening programme, and through the major package of investment of over £20 million to expand research and improve treatment announced on 2 June 2026, the Government is taking an important step forward in tackling the most common cancer in men.

The targeted screening programme, rolling out in 2027, will screen men between the ages of 45 and 61 years old who have a BRCA2 gene variant and a family history of prostate, breast, pancreatic, or ovarian cancer. The UK National Screening Committee has assessed that a targeted screening programme for these high risk men is justified on the basis that prostate cancer occurs more often, at a younger age, and more aggressively for men in this group than for other men. This means that, for this group, the benefits of early detection and treatment would outweigh the harms associated with overdiagnosis and treatment side effects.

It is estimated that approximately 1,500 men in England will be eligible for the targeted prostate cancer screening programme. Based on similar programmes for people with genetic risk factors, uptake is expected to be high.

This is a new programme which will potentially increase early diagnosis rates and survival in the eligible population, who, particularly at younger ages, have an increased risk of prostate cancer, with studies suggesting risks approximately five to seven times higher than average.

The Medical Training (Prioritisation) Act 2026 implements the Government’s commitment in the 10-Year Health Plan to prioritise United Kingdom medical graduates for foundation training places, and to prioritise UK medical graduates and internationally trained doctors with significant National Health Service experience for specialty training places.

For specialty training places starting in 2026, immigration statuses are being used as a proxy to capture applicants who are most likely to have significant experience working in the health service in the UK.

From 2027, immigration status will not automatically determine priority for specialty training. Instead, the act provides a power to specify in regulations any additional groups who will be prioritised by reference to criteria indicating significant experience as a doctor in the health service, or by reference to immigration status. The Department is working with NHS England, the devolved administrations, and other partners as part of the development of those regulations.

We recognise concerns about the impact of the act on those applying in the current application cycle for places, particularly where applicants did not know how prioritisation might affect them. However, delaying action would have prolonged the existing imbalance in training competition, and weakened our ability to plan a sustainable workforce.

International medical graduates who are not prioritised can still apply for postgraduate medical training and will be offered places if vacancies remain after prioritised applicants have received offers.

We recognise that miscarriage can have a devastating impact on women and their families, and we are determined that they receive the support they need. That is why we have committed, in the Renewed Women’s Health Strategy, to closely reviewing the findings presented in the Tommy’s Graded Model of Care study, as part of our broader work on miscarriage care.

No assessment has been made. This Government’s Health Mission will aim to make progress against major diseases, including cancer.

The NHS Long-Term Plan sets out the National Health Service’s key ambitions on cancer to increase the number of cancers diagnosed at stages one and two to 75% by 2028 and to increase the number of people surviving cancer for five years by 55,000 as a result.

NHS England is the accountable commissioner for radiotherapy which is a prescribed specialised service. Standards for service delivery are set out in the service specification, which is available at the following link:

https://www.england.nhs.uk/commissioning/spec-services/npc-crg/group-b/b01/

The Moroccan authorities hold primacy for the investigation into the disappearance of Inaayah Makda, and any request from the Moroccan authorities for assistance from UK law enforcement agencies will be considered on a case-by-case basis.

While the Home Secretary has not had discussions with representatives of the Moroccan authorities, consular assistance continues to be provided by the Foreign, Commonwealth and Development Office.

The Government has been assured by the Moroccan authorities that all leads, and any new leads, will be followed up appropriately.

Tackling anti-social behaviour is a top priority for this Government, and a key part of our Safer Streets Mission to take back our streets.

​We will put thousands of neighbourhood police and community support officers into local communities and crack down on those causing havoc on our high streets by introducing tougher powers, including new Respect Orders to tackle repeat offending.

We will give police the powers they need to take action on dangerous and anti-social electric scooters and bikes so that they will be able to quickly destroy the bikes that they seize from offenders. We will set out more information in due course.

This Government recognises the vital work of legal aid mental health providers in supporting vulnerable people to access justice.

For civil contracts, including Mental Health, the LAA commissions legal aid services across geographic areas called procurement areas. The Legal Aid Agency (LAA) monitors the numbers of providers holding contracts across England and Wales within different categories of law. All procurement areas in the Mental Health category exceed the minimum number of contracts per procurement area. Information about the number of legal aid contract holders is published as part of the LAA’s Official Statistics: Legal aid statistics quarterly: October to December 2025 - GOV.UK [Tables 9.1-9.8].

A detailed breakdown by procurement area in each category can be accessed via the Legal Aid Provider Contract Statistics Dashboard: https://www.gov.uk/government/statistics/a-guide-to-legal-aid-statistics-in-england-and-wales/legal-aid-statistics-data-visualisation-tools.

The LAA will continue to monitor coverage as we approach the implementation of changes that will impact the Mental Health Tribunal as a result of the Mental Health Act 2025. Details regarding additional demand resulting from the Mental Health Act 2025 are set out in the Impact Assessment published alongside the Act (https://bills.parliament.uk/publications/56782/documents/5311).

In preparation for a new standard civil contract in 2028, the LAA will engage with stakeholders including the Mental Health Lawyers Association to gather views on how best to support the sustainability of the market. These insights will inform LAA’s approach and help shape future contracts to reduce administrative burdens and increase flexibility in the way services are delivered.

The Government is making significant investments in legal aid. We have secured additional funding of over £200 million over the Spending Review period for legal aid transformation, recovery from the cyber-attack, and for moving our legacy systems to a modern and secure technology platform. The transformation programme aims to support sustainability for all providers – including those undertaking mental health legal aid work – by ensuring new digital systems streamline processes and reduce administrative burdens.

Travel payments form part of the wider legal aid remuneration system, which is kept under review. HMRC’s Approved Mileage Allowance Payments sit within the tax framework and do not determine legal aid payment rates. Any changes to legal aid travel payments would be considered on their own merits, taking account of the operation and sustainability of the scheme.